Intensive lipid-lowering therapy in high-risk diabetic patients

Hypertens Res. 2021 Dec;44(12):1676-1677. doi: 10.1038/s41440-021-00773-4. Epub 2021 Oct 25.

Author

Masaaki Miyata¹

Affiliation

¹ School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. miyatam@m3.kufm.kagoshima-u.ac.jp.

PMID: 34690352
DOI: 10.1038/s41440-021-00773-4

No abstract available

Publication types

Editorial

MeSH terms

Cholesterol, LDL
Diabetes Mellitus* / drug therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Hypolipidemic Agents / therapeutic use

Substances

Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents